T1	HMM 185 246	efficacy, tolerability and first-dose blood-pressure response
T2	HMM 836 844	Efficacy
T3	HMM 849 857	assessed
T4	HMM 866 1069	six-minute walking test, the New York Heart Association (NYHA) class, a functional lifescale (FLS) questionnaire and the cardiothoracic ratio (CTR)-at study entry and at the end of the maintenance phase.
T5	HMM 1070 1084	Blood pressure
T6	HMM 1336 1395	distance walked during the six-minute walking test improved
T7	HMM 1464 1490	statistically significant.
T8	HMM 1505 1524	significant changes
T9	HMM 1532 1543	FLS or CTR.
T10	HMM 1624 1660	statistically significant difference
T11	HMM 1759 1770	hypotension
T12	HMM 1966 2001	first-dose blood-pressure response.
